American Institute For Advanced Investment Management, LLP Abb Vie Inc. Transaction History

American Institute For Advanced Investment Management, LLP

$141 Million
Q3 2024

A detailed history of American Institute For Advanced Investment Management, LLP transactions in Abb Vie Inc. stock. As of the latest transaction made, American Institute For Advanced Investment Management, LLP holds 8,512 shares of ABBV stock, worth $1.46 Million. This represents 1.19% of its overall portfolio holdings.

Number of Shares

8,512

Previous 8,411 1.2%

Holding current value

$1.46 Million

Previous $1.44 Million 16.5%

% of portfolio

1.19%

Previous 1.11%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 22, 2024	BUY	$163.84 - $199.33 $16,547 - $20,132	101 Added 1.2%	8,512 $1.68 Million
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $4,179 - $4,880	-27 Reduced 0.32%	8,411 $1.44 Million
Q1 2024 Apr 22, 2024	BUY	$159.82 - $182.1 $77,672 - $88,500	486 Added 6.11%	8,438 $1.54 Million
Q4 2023 Jan 23, 2024	SELL	$137.6 - $154.97 $61,507 - $69,271	-447 Reduced 5.32%	7,952 $1.23 Million
Q3 2023 Oct 31, 2023	SELL	$133.59 - $154.65 $36,202 - $41,910	-271 Reduced 3.13%	8,399 $1.25 Million
Q2 2023 Jul 26, 2023	BUY	$132.51 - $164.9 $96,202 - $119,717	726 Added 9.14%	8,670 $1.17 Million
Q1 2023 Apr 28, 2023	SELL	$144.61 - $166.54 $224,000 - $257,970	-1,549 Reduced 16.32%	7,944 $1.27 Million
Q4 2022 Feb 27, 2023	BUY	$138.31 - $165.87 $83,124 - $99,687	601 Added 6.76%	9,493 $1.54 Million
Q4 2022 Jan 19, 2023	SELL	$138.31 - $165.87 $24,895 - $29,856	-180 Reduced 1.98%	8,892 $0
Q3 2022 Oct 25, 2022	BUY	$134.21 - $153.93 $434,169 - $497,963	3,235 Added 55.42%	9,072 $1.22 Million
Q2 2022 Jul 21, 2022	SELL	$137.62 - $174.96 $31,652 - $40,240	-230 Reduced 3.79%	5,837 $894,000
Q1 2022 Apr 20, 2022	SELL	$131.98 - $163.75 $5,279 - $6,550	-40 Reduced 0.65%	6,067 $984,000
Q4 2021 Feb 10, 2022	BUY	$107.43 - $135.93 $4,834 - $6,116	45 Added 0.74%	6,107 $827,000
Q2 2021 Jul 20, 2021	SELL	$105.21 - $117.21 $35,981 - $40,085	-342 Reduced 5.34%	6,062 $683,000
Q1 2021 May 18, 2021	SELL	$102.3 - $112.62 $1,023 - $1,126	-10 Reduced 0.16%	6,404 $693,000
Q3 2020 Oct 07, 2020	SELL	$85.91 - $100.83 $10,738 - $12,603	-125 Reduced 1.91%	6,414 $562,000
Q2 2020 Jul 20, 2020	BUY	$73.37 - $98.18 $233,316 - $312,212	3,180 Added 94.67%	6,539 $642,000
Q4 2019 Mar 19, 2020	BUY	$72.13 - $90.25 $242,284 - $303,149	3,359 New	3,359 $297,000

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $304B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of American Institute For Advanced Investment Management, LLP, based on Form 13F filings with the SEC.

News

Stay updated on American Institute For Advanced Investment Management, LLP with notifications on news.

Account

American Institute For Advanced Investment Management, LLP Abb Vie Inc. Transaction History